Vaccines Are Coming Soon. Is It Time to Sell Stay-at-Home Stocks?
The tide is turning in the fight against the coronavirus.
Two pharmaceutical companies, Pfizer, in partnership with BioNTech, and Moderna, have announced successful phase 3 trial results with efficacy rates above 90% -- much higher than expected -- and a number of other drug companies are on track to release late-stage results in the coming weeks. For Pfizer and Moderna, FDA approval is expected soon, and Dr. Anthony Fauci, the director of the National Institute for Allergy and Infectious Diseases, has said that healthcare workers could have access to a vaccine as soon as December, with the average American being able to get vaccinated by April if things go well.
Image source: Getty Images.
Source Fool.com
